--- title: "Crude Oil Moves Lower; Cintas Raises FY2026 Forecast" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/280520824.md" description: "U.S. stocks rose, with the Dow gaining over 300 points, led by Cintas Corp, which reported strong earnings and raised its FY2026 forecast. Cintas' Q3 EPS was $1.24, exceeding estimates, and sales reached $2.84 billion. Other notable gains included Sarepta Therapeutics and Braze Inc. However, energy stocks fell slightly, and crude oil prices dropped 1.7% to $90.74. Asian and European markets also saw positive movements, while U.S. mortgage applications declined by 10.5%." datetime: "2026-03-25T19:36:29.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/280520824.md) - [en](https://longbridge.com/en/news/280520824.md) - [zh-HK](https://longbridge.com/zh-HK/news/280520824.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/280520824.md) | [English](https://longbridge.com/en/news/280520824.md) # Crude Oil Moves Lower; Cintas Raises FY2026 Forecast U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Wednesday. The Dow traded up 0.60% to 46,402.31 while the NASDAQ rose 0.63% to 21,899.66. The S&P 500 also rose, gaining, 0.49% to 6,588.77. Check This Out: How To Earn $500 A Month From Goldman Sachs Stock Ahead Of Q4 Earnings **Leading and Lagging Sectors** Materials shares climbed by 2% on Wednesday. In trading on Wednesday, energy stocks fell by 0.2%. **Top Headline** **Cintas Corp** (NASDAQ:CTAS) posted better-than-expected third-quarter profit and raised its full-year forecast. The company reported third-quarter earnings per share of $1.24, beating the analyst consensus estimate of $1.23. Quarterly sales of $2.84 billion, up 8.9% year over year, beat the Street view of $2.821 billion. The company raised FY2026 sales outlook from $11.150 billion-$11.220 billion to $11.210 billion-$11.240 billion versus street view of $11.205 billion. **Equities Trading UP**            - **Sarepta Therapeutics Inc** (NASDAQ:SRPT) shares shot up 30% to $22.90 after the company announced that early results from Phase 1/2 studies of SRP-1001 for facioscapulohumeral muscular dystrophy type 1 and SRP-1003 for myotonic dystrophy type 1. Also, the company generated proof-of-concept data for SRP-1001 and SRP-1003. - Shares of **Braze Inc** (NASDAQ:BRZE) got a boost, surging 21% to $21.72 after the company reported better-than-expected fourth-quarter sales results and issued FY27 sales guidance above estimates. Also, the company announced a $100 million share buyback. - **Arm Holdings PLC – ADR** (NASDAQ:ARM) shares were also up, gaining 18% to $159.00 after the company announced that it expects its new AGI CPU to generate approximately $15 billion in annual revenue in five years. **Equities Trading DOWN** - **Anavex Life Sciences Corp** (NASDAQ:AVXL) shares dropped 35% to $2.74 after the company announced that it withdrew its application for European Medicines Agency marketing authorization of blarcamesine in the EU as an add-on therapy for the treatment of early Alzheimer’s disease in adults. - Shares of **Maze Therapeutics Inc** (NASDAQ:MAZE) were down 33% to $32.75 after the company announced fourth-quarter results. - **Velo3D Inc** (NASDAQ:VELO) was down, falling 22% to $10.60 after the company reported quarterly financial results. Also, the company announced the appointment of James Suva as CFO. **Commodities** In commodity news, oil traded down 1.7% to $90.74 while gold traded up 3.4% at $4,551.10. Silver traded up 4.3% to $72.555 on Wednesday, while copper rose 2% to $5.56. **Euro zone** European shares were higher today. The eurozone's STOXX 600 rose 1.42%, while Spain's IBEX 35 Index rose 1.54%. London's FTSE 100 rose 1.42%, Germany's DAX gained 1.41% and France's CAC 40 rose 1.33% during the session. **Asia Pacific Markets** Asian markets closed higher on Wednesday, with Japan's Nikkei 225 gaining 2.87%, Hong Kong's Hang Seng index gaining 1.09%, China's Shanghai Composite rising 1.30% and India's BSE Sensex surging 1.63%. **Economics** - U.S. crude inventories jumped by 6.926 million barrels to 456.2 million barrels in the week ended March 20, versus market estimates of a 0.5 million-barrel gain. - The U.S. current account deficit shrank to $190.7 billion in the fourth quarter from $239.1 billion in the prior period. - U.S. mortgage applications fell by 10.5% from the previous week in the week ending March 20, following a 10.9% decline in the previous week. _Photo via Shutterstock_ ### 相關股票 - [Cintas (CTAS.US)](https://longbridge.com/zh-HK/quote/CTAS.US.md) - [Dow Jones Utility Average (.DJU.US)](https://longbridge.com/zh-HK/quote/.DJU.US.md) - [Dow Jones Industrial Average (.DJI.US)](https://longbridge.com/zh-HK/quote/.DJI.US.md) - [Occidental Petroleum (OXY.US)](https://longbridge.com/zh-HK/quote/OXY.US.md) - [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md) - [ISHRS S&P Glb Engy (IXC.US)](https://longbridge.com/zh-HK/quote/IXC.US.md) - [iShares US Oil Equip & Svcs (IEZ.US)](https://longbridge.com/zh-HK/quote/IEZ.US.md) - [iShares US Oil & Gas Expl & Prod (IEO.US)](https://longbridge.com/zh-HK/quote/IEO.US.md) - [United States Oil Fund LP (USO.US)](https://longbridge.com/zh-HK/quote/USO.US.md) - [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-HK/quote/IBBQ.US.md) - [VG Energy (VDE.US)](https://longbridge.com/zh-HK/quote/VDE.US.md) - [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md) - [Us Brent Oil (BNO.US)](https://longbridge.com/zh-HK/quote/BNO.US.md) - [SPDR O&G Equip (XES.US)](https://longbridge.com/zh-HK/quote/XES.US.md) - [Pro Ultr Bloomberg Crude Oil (UCO.US)](https://longbridge.com/zh-HK/quote/UCO.US.md) - [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md) - [Tradr 2X Long SRPT Daily ETF (SRPU.US)](https://longbridge.com/zh-HK/quote/SRPU.US.md) - [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md) - [Direxion S&P Biotech Bull 3X (LABU.US)](https://longbridge.com/zh-HK/quote/LABU.US.md) - [SPDR O&G Ex & Prd (XOP.US)](https://longbridge.com/zh-HK/quote/XOP.US.md) - [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md) - [VanEck Oil Refiners ETF (CRAK.US)](https://longbridge.com/zh-HK/quote/CRAK.US.md) - [VanEck Oil Services ETF (OIH.US)](https://longbridge.com/zh-HK/quote/OIH.US.md) - [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md) - [SPDR Energy Select (XLE.US)](https://longbridge.com/zh-HK/quote/XLE.US.md) - [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md) - [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-HK/quote/ARKG.US.md) ## 相關資訊與研究 - [Trump metals tariffs cut to 15% for some industrial, power grid equipment through 2027](https://longbridge.com/zh-HK/news/281569667.md) - [US inflation set to spike as energy prices rise amid West Asia war](https://longbridge.com/zh-HK/news/281696973.md) - [Aberdeen Group plc Trims Position in Cintas Corporation $CTAS](https://longbridge.com/zh-HK/news/281676901.md) - [(CTAS) Cintas Expects Fiscal 2026 Adjusted EPS Range $4.86 to $4.90, vs. FactSet Est of $4.88](https://longbridge.com/zh-HK/news/280474484.md) - [Near-term oil prices hit record premium over later deliveries after Trump vows more attacks on Iran](https://longbridge.com/zh-HK/news/281570397.md)